PATTIES FOODS (PH4) - Net Assets
Based on the latest financial reports, PATTIES FOODS (PH4) has net assets worth €616.77 Million EUR (≈ $721.07 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€1.36 Billion ≈ $1.59 Billion USD) and total liabilities (€741.60 Million ≈ $867.01 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check PH4 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €616.77 Million |
| % of Total Assets | 45.41% |
| Annual Growth Rate | -26.9% |
| 5-Year Change | -48.9% |
| 10-Year Change | N/A |
| Growth Volatility | 48.32 |
PATTIES FOODS - Net Assets Trend (2020–2025)
This chart illustrates how PATTIES FOODS's net assets have evolved over time, based on quarterly financial data. Also explore how large is PATTIES FOODS's balance sheet for the complete picture of this company's asset base.
Annual Net Assets for PATTIES FOODS (2020–2025)
The table below shows the annual net assets of PATTIES FOODS from 2020 to 2025. For live valuation and market cap data, see PATTIES FOODS (PH4) market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | €616.77 Million ≈ $721.07 Million |
+69.50% |
| 2024-12-31 | €363.87 Million ≈ $425.40 Million |
-20.35% |
| 2023-12-31 | €456.83 Million ≈ $534.08 Million |
+1.67% |
| 2022-12-31 | €449.33 Million ≈ $525.31 Million |
-62.77% |
| 2021-12-31 | €1.21 Billion ≈ $1.41 Billion |
-59.15% |
| 2020-12-31 | €2.95 Billion ≈ $3.45 Billion |
-- |
Equity Component Analysis
This analysis shows how different components contribute to PATTIES FOODS's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 954793700000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | €10.16 Billion | 1648.06% |
| Total Equity | €616.77 Million | 100.00% |
PATTIES FOODS Competitors by Market Cap
The table below lists competitors of PATTIES FOODS ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Dampskibsselskabet Norden AS
CO:DNORD
|
$1.44 Billion |
|
Engineers India Limited
NSE:ENGINERSIN
|
$1.44 Billion |
|
Akzo Nobel India Limited
NSE:AKZOINDIA
|
$1.44 Billion |
|
Beijing Urban Construction Investment & Development Co Ltd
SHG:600266
|
$1.44 Billion |
|
Flight Centre Travel Group Ltd
AU:FLT
|
$1.44 Billion |
|
Nabors Industries Ltd.
NYSE:NBR
|
$1.44 Billion |
|
Companhiade Eletricidade do Estado da Bahia - COELBA
SA:CEEB3
|
$1.44 Billion |
|
Kelt Exploration Ltd.
TO:KEL
|
$1.44 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in PATTIES FOODS's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 363,871,000 to 616,769,000, a change of 252,898,000 (69.5%).
- Net loss of 437,003,000 reduced equity.
- New share issuances of 672,464,000 increased equity.
- Other factors increased equity by 17,437,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-437.00 Million | -70.85% |
| Share Issuances | €672.46 Million | +109.03% |
| Other Changes | €17.44 Million | +2.83% |
| Total Change | €- | 69.50% |
Book Value vs Market Value Analysis
This analysis compares PATTIES FOODS's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.01x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has increased from 0.34x to 2.01x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-12-31 | €2.52 | €0.84 | x |
| 2021-12-31 | €1.02 | €0.84 | x |
| 2022-12-31 | €0.38 | €0.84 | x |
| 2023-12-31 | €0.36 | €0.84 | x |
| 2024-12-31 | €0.29 | €0.84 | x |
| 2025-12-31 | €0.42 | €0.84 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently PATTIES FOODS utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -70.85%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -162.10%
- • Asset Turnover: 0.20x
- • Equity Multiplier: 2.20x
- Recent ROE (-70.85%) is above the historical average (-96.27%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | -41.33% | -117.54% | 0.28x | 1.27x | €-1.52 Billion |
| 2021 | -159.08% | -787.84% | 0.11x | 1.88x | €-2.04 Billion |
| 2022 | -200.90% | -187.53% | 0.29x | 3.65x | €-947.61 Million |
| 2023 | -80.39% | -79.17% | 0.28x | 3.64x | €-412.92 Million |
| 2024 | -25.07% | -22.40% | 0.29x | 3.83x | €-127.59 Million |
| 2025 | -70.85% | -162.10% | 0.20x | 2.20x | €-498.68 Million |
Industry Comparison
This section compares PATTIES FOODS's net assets metrics with peer companies in the Biotechnology industry.
Industry Context
- Industry: Biotechnology
- Average net assets among peers: $429,291,566
- Average return on equity (ROE) among peers: -57.45%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| PATTIES FOODS (PH4) | €616.77 Million | -41.33% | 1.20x | $1.44 Billion |
| PROQR THERAPEUTICS EO-04 (0PQ) | $41.39 Million | -67.94% | 2.33x | $142.34 Million |
| TIZIANA LIFE SCIENCES LTD (0RP) | $3.94 Million | -301.40% | 1.87x | $161.62 Million |
| Theravance Biopharma Inc (0TB) | $-51.59 Million | 0.00% | 0.00x | $828.57 Million |
| I-MAB SPONS.ADS/1 -0001 (0VY) | $421.77 Million | -87.98% | 0.40x | $202.81 Million |
| PreveCeutical Medical Inc (18H) | $-4.49 Million | 0.00% | 0.00x | $3.34 Million |
| Argen-X (1AE) | $2.53 Billion | -16.11% | 0.12x | $41.67 Billion |
| WAVE LIFE SCIENCES LTD. (1U5) | $518.36 Million | -39.43% | 0.23x | $1.14 Billion |
| BIOCURE TECHNOLOGY INC. (1WH) | $1.34 Million | -19.58% | 0.49x | $960.84K |
| ZAI LAB LTD0000006 (1ZLB) | $796.12 Million | -42.03% | 0.30x | $1.82 Billion |
| BioNTech SE (22UA) | $31.86 Million | 0.00% | 11.24x | $20.05 Billion |
About PATTIES FOODS
CStone Pharmaceuticals, a biopharmaceutical company, researches and develops anti-cancer therapies to address the unmet medical needs of cancer patients in Mainland China and internationally. The company offers CEJEMLY (sugemalimab), a monoclonal antibody against programmed death (PD) ligand 1 for the treatment of non-small cell lung cancer (NSCLC), gastric adenocarcinoma/gastroesophageal junctio… Read more